Pancreatic Cancer Research

ResearcherNo recent work listed

Emiliano Calvo Aller

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4921-829X; OpenAlex author ID A5053069942. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer. Co-author DOI 10.1136/jitc-2020-002068↗
  2. A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients. Last author DOI 10.1186/s12885-017-3131-x↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anna M. Varghese · 1 shared paper, 2021 · strength 0.10
  2. Ivelina Gueorguieva · 1 shared paper, 2021 · strength 0.10
  3. Karim Adnane Benhadji · 1 shared paper, 2021 · strength 0.10
  4. Valeria Merz · 1 shared paper, 2021 · strength 0.10
  5. Rocio García‐Carbonero · 1 shared paper, 2021 · strength 0.10
  6. Do‐Youn Oh · 1 shared paper, 2021 · strength 0.10
  7. Antoine Hollebecque · 1 shared paper, 2021 · strength 0.10
  8. Davide Melisi · 1 shared paper, 2021 · strength 0.10
  9. Erkut Hasan Borazanci · 1 shared paper, 2021 · strength 0.10
  10. Teresa Mercade Macarulla · 1 shared paper, 2021 · strength 0.10
  11. Dick J. Richel · 1 shared paper, 2017 · strength 0.05
  12. Donald Richards · 1 shared paper, 2017 · strength 0.05
  13. Berta Laquente · 1 shared paper, 2017 · strength 0.05
  14. George Kim · 1 shared paper, 2017 · strength 0.05
  15. Tudor–Eliade Ciuleanu · 1 shared paper, 2017 · strength 0.05
  16. Stefano Cascinu · 1 shared paper, 2017 · strength 0.05
  17. Daniel D. Von Hoff · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.